What was Identifai Genetics Limited’s price range in the past 12 months?
Identifai Genetics Limited lowest share price was AU$0.22 and its highest was AU$0.56 in the past 12 months.
What is Identifai Genetics Limited’s market cap?
Identifai Genetics Limited’s market cap is AU$67.19M.
When is Identifai Genetics Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Identifai Genetics Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Identifai Genetics Limited pay dividends?
Identifai Genetics Limited does not currently pay dividends.
What is Identifai Genetics Limited’s EPS estimate?
Identifai Genetics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Identifai Genetics Limited have?
Identifai Genetics Limited has 191,979,020 shares outstanding.
Which hedge fund is a major shareholder of Identifai Genetics Limited?
Currently, no hedge funds are holding shares in AU:ID1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.